CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands		6 Months Ended
		Dec. 31, 2025	Dec. 31, 2024
Cash flows provided by (used in) operating activities:
Net income		$ 1,812	$ 6,792
Adjustments to reconcile net income to cash provided by operating activities:
Gain from sale of OSP (Note 3)		0	(8,396)
Depreciation and amortization		1,548	853
Deferred income taxes		1,361	(197)
Non-cash interest		2,897	2,513
Gain on earn-out liability		(1,000)	0
Long-lived asset impairment		0	352
Stock-based compensation		910	1,604
Amortization of debt discount and financing costs		1,811	1,605
Other non-cash items affecting earnings		(127)	569
Ad fund		(250)	3,474
Changes in operating assets and liabilities	[1]	(5,016)	(8,382)
Net cash provided by operating activities		3,946	787
Cash flows (used in) provided by investing activities:
Capital expenditures		(1,167)	(444)
Asset acquisitions, net of cash acquired and certain obligations assumed		0	(18,631)
Proceeds from sale of OSP, net of fees		0	8,463
Net cash used in investing activities		(1,167)	(10,612)
Cash flows (used in) provided by financing activities:
Borrowings on revolving credit facility		0	4,326
Repayments of revolving credit facility		0	(10,238)
Repayments of long-term debt		(2,140)	(526)
Debt refinancing fees		(41)	(814)
Proceeds from issuance of common stock in connection with warrant exercise		298	0
Proceeds from issuance of common stock for options exercised		606	0
Proceeds from issuance of long-term debt		0	15,000
Taxes paid for shares withheld		(161)	(75)
Net cash (used in) provided by financing activities		(1,438)	7,673
Effect of exchange rate changes on cash and cash equivalents		(2)	(106)
Increase (decrease) in cash, cash equivalents, and restricted cash		1,339	(2,258)
Cash, cash equivalents, and restricted cash:
Beginning of period		35,205	29,312
End of period		$ 36,544	$ 27,054

[1] Changes in operating assets and liabilities exclude ad fund and assets and liabilities sold or acquired.